51. Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
- Author
-
Shwetha Mangalesh, Debashish Das, Supriya Dabir, Naresh Kumar Yadav, Jan S. A. G. Schouten, Jeyabalan Nallathambi, Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - Clinical epidemiology, RS: MHeNs - R3 - Neuroscience, and Oogheelkunde
- Subjects
Oncology ,Male ,Pathology ,pinguecula ,cell-based therapy ,rural areas ,Visual Acuity ,Antioxidants ,Symposium - TRIP ,iPhone ,lcsh:Ophthalmology ,pterygium ,Prospective Studies ,glutathione ,Laser Coagulation ,limbus ,pattern laser ,Standard treatment ,smart phones ,2-ethylpyridine ,middle-income countries ,Bevacizumab ,corneoplastique ,retinal imaging ,cone spacing ,Retinopathy ,medicine.medical_specialty ,autograft ,Intacs ,subthreshold micropulse laser ,RETINOPATHY ,radial keratotomy ,mitochondrial membrane potential ,stem cells ,corneal scars ,Humans ,Diabetic Retinopathy ,screening ,non-physician graders ,Case-control study ,medicine.disease ,retinal photocoagulation ,Ophthalmology ,glaucoma ,lcsh:RE1-994 ,Case-Control Studies ,CELLS ,ARPE-19 cells ,microarray analysis ,Retcam ,Angiogenesis ,PATHOGENESIS ,Angiogenesis Inhibitors ,Allograft ,oxidative stress ,wide-field digital imaging ,Prospective cohort study ,apoptosis ,Diode laser ,Diabetic retinopathy ,Middle Aged ,niche ,astigmatism ,Treatment Outcome ,Eye movement perimeter ,gene expression profile ,Female ,telemedicine ,tele-ophthalmology ,Infant blindness ,diabetic macular edema ,Tomography, Optical Coherence ,electromagnetic ration ,medicine.drug ,cigarette smoke toxicant ,lens ,keratoconus ,saccadic reaction time ,limbal transplantation ,retinopathy of prematurity (ROP) ,Macular Edema ,nomogram ,reactive oxygen/nitrogen species ,Internal medicine ,medicine ,premium cataract surgery ,refractive complications ,business.industry ,Gene Expression Profiling ,tele-ROP ,yellow laser ,limbal stem cell deficiency ,Gene expression profiling ,Gene Expression Regulation ,RNA ,cone count ,business ,Lasik ,Adaptive optics ,MATRIX - Abstract
Introduction: Diabetic macular edema (DME) is a vision-threatening complication of diabetic retinopathy. The current practice of management is a" trial and error "method of using intravitreal antivascular endothelial growth factor (VEGF)'' or steroids to treat the patient and watch the response. However, if the patient's genetic profile helps us choose appropriate medicine, it would help customize treatment option for each patient. This forms the basis of our study. Materials and Methods: A case-control, prospective, observational series, where DME patients were treated with bevacizumab and subclassified as treatment naive, treatment responders, and treatment nonresponders. Blood samples of 20 subjects were studied, with five patients in each of the groups (nondiabetic-group 1, treatment naive-group 2, treatment responder-group 3, and treatment nonresponder-group 4). Whole blood RNA extraction followed by labeling, amplification and hybridization was done, and microarray data analyzed. Genes were classified based on functional category and pathways. Results: The total number of genes upregulated among all three experimental groups was 5, whereas 105 genes were downregulated. There were no common genes upregulated between the responders and nonresponders. There was only one gene upregulated between the diabetic and diabetic responders posttreatment. There were 19 genes upregulated and 8 genes downregulated in the inflammatory pathway in group 2 versus group 1. There were no downregulated genes detected in vascular angiogenesis and transcription group. There were identical numbers of genes up-and downregulated in the inflammatory pathway. Seventeen genes were upreguated and 11 genes downregulated in receptor activity, which remained the predominant group in the group classification. Discussion: In summary, this study would provide an insight into the probable signaling mechanisms for disease pathogenesis as well as progression. This type of study eventually would aid in developing or improvising existing treatment modules with a rational approach towards personalized medicine, in future addressing the differential responses to treatment.
- Published
- 2014